Recent Posts
Connect with:
Tuesday / June 25.
HomemiproductsEikance 0.01%

Eikance 0.01%

Eikance 0.01%, the first pharmacotherapy registered on the Australian Register of Therapeutic Goods to slow the progression of myopia in children aged four to 14 years,1# may be initiated in children when myopia progresses ≥-1.0 D per year.1

Eikance 0.01% single-use ampoules are sealed in foil pouches and are available in packs of 30 x 0.3 mL ampoules. The ophthalmic solution is sterile and preservative-free. Eikance 0.01% is a prescription only medicine available at pharmacies across Australia.

Contact: Aspen Pharmaceuticals (AUS) 02 8436 8300

PBS information: This product is not listedon the Pharmaceutical Benefits Scheme (PBS)

Before prescribing, please review full product information on page 13 of this issue of mivision or scan here to access product information.

▼ This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems. # Australian Register of Therapeutic Goods. Accessed: 11 March 2024.


1.Eikance approved product information. AU-ATR-032024-08305.

This article is restricted to
Verified Health Practitioners only

Already registered?